Reiko Kishi Selected Research

perfluorotridecanoic acid

10/2020	Effect of prenatal exposure to per- and polyfluoroalkyl substances on childhood allergies and common infectious diseases in children up to age 7 years: The Hokkaido study on environment and children's health.
1/2020	Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study.
4/2014	Prenatal exposure to perfluoroalkyl acids and allergic diseases in early childhood.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Reiko Kishi Research Topics

Disease

22	Hypersensitivity (Allergy) 01/2022 - 01/2006
22	Birth Weight (Birth Weights) 01/2020 - 01/2004
7	Asthma (Bronchial Asthma) 01/2022 - 05/2009
7	Genetic Predisposition to Disease (Genetic Predisposition) 12/2017 - 12/2005
6	Eczema 01/2022 - 04/2014
6	Communicable Diseases (Infectious Diseases) 10/2020 - 01/2012
6	Sick Building Syndrome 01/2018 - 05/2009
6	Spontaneous Abortion (Miscarriage) 09/2006 - 03/2004
5	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 01/2018
5	Conjunctivitis 01/2022 - 04/2012
5	Infections 01/2018 - 09/2007
5	Hypospadias 08/2010 - 01/2005
4	Respiratory Sounds (Crackle) 01/2022 - 01/2018
4	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2013 - 01/2004
4	Neoplasms (Cancer) 05/2007 - 06/2002
4	Cryptorchidism (Undescended Testes) 01/2006 - 01/2003
3	Obesity 08/2021 - 01/2018
3	Inflammation (Inflammations) 01/2021 - 07/2007
3	Allergic Rhinitis 06/2020 - 04/2012
3	Hypertension (High Blood Pressure) 07/2011 - 01/2006
3	Insulin Resistance 08/2009 - 08/2007
2	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 01/2022 - 01/2004
2	Neurodevelopmental Disorders 11/2021 - 11/2013
2	Congenital Abnormalities (Deformity) 05/2021 - 04/2019
2	Premature Birth (Birth, Premature) 01/2019 - 01/2013
2	Atopic Dermatitis (Atopic Eczema) 07/2014 - 10/2013
2	Body Weight (Weight, Body) 06/2012 - 01/2003
2	Hypotension (Low Blood Pressure) 07/2011 - 01/2009
2	Hyperlipidemias (Hyperlipidemia) 07/2011 - 01/2009
2	Diabetes Mellitus 07/2011 - 01/2009
2	Pregnancy Complications 09/2009 - 03/2008
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 08/2009 - 08/2007
2	Carcinogenesis 05/2007 - 08/2004
2	Pain (Aches) 01/2005 - 01/2003
2	Lung Neoplasms (Lung Cancer) 10/2002 - 06/2002
1	Pre-Eclampsia (Preeclampsia) 01/2022
1	Weight Gain 01/2022

Drug/Important Bio-Agent (IBA)

7	ORALIT (ORS)IBA 01/2022 - 10/2013
7	phthalic acid (phthalate)IBA 01/2022 - 07/2014
7	SmokeIBA 12/2019 - 01/2003
7	DioxinsIBA 01/2018 - 01/2006
6	Folic Acid (Vitamin M)FDA LinkGeneric 05/2021 - 01/2012
6	CytokinesIBA 05/2009 - 04/2004
5	Hormones (Hormone)IBA 01/2018 - 01/2003
4	Volatile Organic CompoundsIBA 11/2021 - 05/2009
4	Immunoglobulin E (IgE)IBA 06/2020 - 01/2012
4	Tobacco Smoke Pollution (Passive Smoking)IBA 12/2019 - 11/2013
4	Dust (House Dust)FDA Link 12/2018 - 07/2014
4	Diethylhexyl Phthalate (DEHP)IBA 01/2018 - 07/2014
4	Polychlorinated Dibenzodioxins (TCDD)IBA 11/2013 - 05/2007
4	EnzymesIBA 09/2009 - 01/2004
3	perfluorooctaneIBA 10/2020 - 12/2015
3	perfluorotridecanoic acidIBA 10/2020 - 04/2014
3	perfluorooctanoic acidIBA 10/2020 - 12/2015
3	Phosphates (Orthophosphate)IBA 01/2020 - 10/2018
3	CotinineIBA 12/2019 - 12/2017
3	mono-(2-ethylhexyl)phthalateIBA 03/2018 - 05/2015
3	AllergensIBA 01/2018 - 09/2009
3	AdipokinesIBA 02/2017 - 03/2009
3	AndrogensIBA 08/2010 - 06/2005
3	Polychlorinated Biphenyls (PCBs)IBA 10/2009 - 02/2008
3	Estrogens (Estrogen)FDA Link 06/2008 - 01/2003
3	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 02/2008 - 06/2005
3	Diethylstilbestrol (Stilbestrol)FDA Link 01/2006 - 01/2003
3	Endocrine DisruptorsIBA 01/2006 - 01/2003
2	CholesterolIBA 01/2022 - 01/2006
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2020
2	AntibodiesIBA 01/2022 - 12/2019
2	hydroxide ionIBA 01/2022 - 10/2018
2	Thyroid HormonesIBA 01/2022 - 02/2018
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2022 - 08/2004
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022 - 08/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 06/2005
2	bisphenol AIBA 01/2021 - 01/2018
2	AcidsIBA 01/2021 - 01/2017
2	perfluorodecanoic acidIBA 10/2020 - 01/2020
2	Flame Retardants (Fire Retardants)IBA 01/2020 - 12/2018
2	PlasticizersIBA 01/2020 - 05/2009
2	Caffeine (No Doz)FDA LinkGeneric 01/2019 - 01/2017
2	MercuryIBA 01/2019 - 11/2015
2	Biological ProductsIBA 01/2018 - 01/2003
2	AdiponectinIBA 02/2017 - 08/2009
2	Glucose (Dextrose)FDA LinkGeneric 07/2011 - 01/2009
2	Triglycerides (Triacylglycerol)IBA 07/2011 - 01/2009
2	lipoprotein cholesterolIBA 07/2011 - 01/2009
2	NitrosaminesIBA 09/2009 - 03/2008
2	Polychlorinated DibenzofuransIBA 09/2009 - 02/2008
2	C-Reactive ProteinIBA 05/2009 - 08/2006
2	PesticidesIBA 05/2009 - 01/2005
2	HDL CholesterolIBA 01/2009 - 01/2006
2	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 03/2008 - 02/2008
2	Interleukin-6 (Interleukin 6)IBA 09/2007 - 07/2007
2	InterleukinsIBA 06/2005 - 04/2004
2	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 06/2005 - 01/2004
2	GenisteinIBA 08/2004 - 01/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2004 - 04/2004
1	Blood Glucose (Blood Sugar)IBA 01/2022

Therapy/Procedure

2	Induced Abortion (Induced Abortions) 09/2006 - 06/2005
2	Activities of Daily Living (ADL) 01/2005 - 01/2003
1	Ambulatory Care (Outpatient Care) 01/2022